1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
MicroRNA Market Size, Share & Trends Analysis Report By Research Tools, By Application By End-use And Segment Forecasts, 2018 - 2025

MicroRNA Market Size, Share & Trends Analysis Report By Research Tools, By Application By End-use And Segment Forecasts, 2018 - 2025

  • May 2018
  • 200 pages
  • ID: 5445402
  • Format: PDF
  • By Grand View Research

Summary

Table of Contents

MicroRNA (miRNA) Market Size, Share & Trends Analysis Report By Research Tools, By Application (Cancer, Neurological Disease, Immunological Disorder, Infectious Diseases) By End-use, And Segment Forecasts, 2018 - 2025

The global microRNA (abbreviated miRNA) market size is expected to reach USD 626.27 million by 2025 posting a CAGR of 18.6% during the forecast period. A significant role of microRNAs in regulating gene expression. Their rapid adoption in development of diagnostic & prognostic tools for various cancer types is anticipated to provide a fillip to the market.

Recent innovations in miRNA applications such as their use as potential biomarkers in advanced diagnostics have accelerated new product development.Based on existing technologies used in gene analysis such as microarrays, qRT-PCR, and sequencing, new products are being developed for better usage of miRNA.

These are designed to overcome challenges faced when working with miRNA.

Investments in development of therapeutics & diagnostic tests based on miRNAs have increased tremendously over past few years.Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics are some major companies involved in the development of RNA-based therapeutics.

These players are involved in strategic partnerships to enhance their capabilities. For instance, in February 2018, STA Pharmaceutical Co., Ltd., a manufacturer of technology platform for small molecule pharmaceutical development signed an agreement with Regulus Therapeutics to provide its manufacturing facility to the company.

Academic & government research organizations are key revenue contributors as large number of microRNA research is carried out in these institutes.However, rising interest of biotech & pharmaceutical companies in miRNAs as biomarkers, especially in cancer screening, is providing a significant push to the market.

MiRNA regulating gene expressions in Alzheimer’s diseases, Autism Spectrum Disorders (ASD), Schizophrenia, and Parkinson’s diseases have been identified. Soaring need for easy diagnosis of these diseases is projected to further increase demand for miRNA research tools.

Instruments used in miRNA analysis, especially those based on advanced technology, are expensive.However, processes performed are available at reasonable prices through service providers.

MiRNA analysis is a part of genomic analysis, thereby many service providers for the genomics market have extended their service offering to this market as well.Novel approaches for handling targeted delivery of miRNAs are being developed.

Nanoparticle-based delivery and miRNA conjugation with other small molecules are few of the potential approaches being studied. Focus on development of approaches to overcome challenges in the delivery of miRNA therapeutics is estimated to propel the market over the forecast period.

Further Key Findings from the Report Suggest:
• Growing competition among miRNA-based therapeutic companies to develop tests & biomarkers for clinical use is likely to boost the demand for miRNA detection services
• Rapid high-quality results coupled with declining sequencing prices are poised to drive adoption of NGS services for miRNA functional studies.
• North America dominated the microRNA market owing to presence of large scale genetic research programs being conducted by universities in the U.S. and Canada. MiRNA profiling studies in these regions are supported by international public functional genomic data repositories such as Gene Expression Omnibus
• Asia Pacific is projected to witness phenomenal CAGR owing to rapid progress in precision medicine & genomics. Owing to the immense potential in APAC, international players are adopting M&A strategies to consolidate their position in the region
• The market is moderately consolidated and competitive in nature due to presence of several multinational players
• Some key companies present in the market are Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); and NanoString Technologies; Inc. The prominence of these players can be attributed to their well-established technical capabilities in other fields of biotechnology.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Antibody Drug Conjugates Market (5th Edition), 2019-2030

Antibody Drug Conjugates Market (5th Edition), 2019-2030

  • $ 4499
  • August 2019

INTRODUCTIONWith six approved and marketed drugs, namely POLIVY™ (2019), LUMOXITI™ (2018), BESPONSA® (2017), MYLOTARG™ (2017, reapproval), KADCYLA® (2013) and ADCETRIS® (2011), antibody drug conjugates ...

Heparin Industry Forecasts - China Focus

Heparin Industry Forecasts - China Focus

  • $ 1800
  • October 2019

This study focuses on China’s Heparin industry forecasts.In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consume ...

Abuse Deterrent Formulation Technologies Market, 2019-2030

Abuse Deterrent Formulation Technologies Market, 2019-2030

  • $ 4499
  • July 2019

INTRODUCTIONAlthough the healthcare industry relies on patient to take medications responsibly, in 2017, close to 18 million individuals were reported to have misused prescription drugs, in the US. In ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on